The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Know the risks and potential benefits of clinical studies and talk to your health care provider before participating.
Read our disclaimer for details.
Firstly, this study aims at clarifying the current situation of Emergency treatment of aneurysmal subarachnoid hemorrhage (SAH) in China, and analyzing the influencing factors contributing to transport delay, so as to improve the efficiency of emergency treatment; Secondly, comparison and analysis of different surgical treatment of aneurysmal SAH would be undertook, so as to improve the diagnosis and treatment of aneurysmal SAH.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Layout table for eligibility information
Ages Eligible for Study:
Child, Adult, Older Adult
Sexes Eligible for Study:
Accepts Healthy Volunteers:
patients presented with subarachnoid hemorrhage and diagnosed with ruptured aneurysm at all age.
patients presented with subarachnoid hemorrhage on CT or lumbar puncture.
the intracranial hemorrhage was caused by rupture of aneurysm and was confirmed on CTA、MRA or DSA.
patients willing to participate in this clinical trial and attach to regular follow up.
intracranial aneurysm correlating to AVM.
dissection, false, traumatic and infectious aneurysms.
the rupture of the aneurysm can not be confirmed on CTA、MRA or DSA.